Identification of MPN-specific Antigens and Anti-MPN TCRs in Myeloproliferative Neoplasm

Abroad (travel likely)Recruiting

Conditions

Myeloproliferative Neoplasm (MPN) · Polycytemia Vera · Essential Thrombocythemia (ET) · Primary Myelofibrosis (PMF)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

de Duve Institute, UCLouvain, Brussels, Woluwe, Belgium
Contact: Study coordinator (Sophie Lucas, Pr) · sophie.lucas@uclouvain.be · 0032 (0)2 436 23 00
Contact: Principal Investigator (Violaine Havelange)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms

Myeloproliferative Neoplasm · MPN · Essential Thrombocythemia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Irvine, United States · Orange, United States

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

Polycythemia Vera · ET (Essential Thrombocythemia) · Polycythemia Vera (PV)

Abroad (travel likely)Recruiting

Chicago, United States · New York, United States

Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm

Myelofibrosis · Essential Thrombocythemia · MPN

Abroad (travel likely)RecruitingPHASE1

New York, United States

Asian Myeloproliferative Neoplasm (MPN) Registry

Myeloproliferative Neoplasm · Polycythemia Vera · Essential Thrombocythemia

Abroad (travel likely)Recruiting

Hong Kong, Hong Kong